LNTH 2505

N/A

Report date: 2025/07/09 16:10:22

Base Information

Drug NameLNTH 2505
Drug Alias NameLNTH 2505EVG-311
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionIonising radiation emittersRadionuclide imaging enhancers
TargetsUpdating
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLantheus Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesLantheus Holdings Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A